LUCD News

The IPO market remained active this past week as seven IPOs raised $2.1 billion. SPAC activity kept steady with 10 blank check IPOs raising $1.6 billion. New filers continued to pour into the IPO pipeline, with 12 IPOs and nine SPACs submitting initial filings. Software development platform GitLab (GTLB) priced above the upwardly revised range to raise $801...read more

Lucid Diagnostics, which makes diagnostic tests for esophageal precancer and cancer, raised $70 million by offering 5 million shares at $14, the low end of the range of $14 to $16. Lucid is a commercial-stage medical diagnostics technology company focused on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer,...read more

The Fall IPO market is expected to stay busy with eight IPOs schedule to raise $1.9 billion in the week ahead. Software development platform GitLab (GTLB) plans to raise $598 million at a $9.4 billion market cap. This founder-led company provides an end-to-end DevOps platform to accelerate the software development cycle from weeks to minutes and enable rapid,...read more

Lucid Diagnostics, which makes diagnostic tests for esophageal precancer and cancer, announced terms for its IPO on Thursday. The New York, NY-based company plans to raise $75 million by offering 5 million shares at a price range of $14 to $16. At the midpoint of the proposed range, Lucid Diagnostics would command a fully diluted market value of $575 million. Lucid is a...read more